MEDNAX INC

 MDのチャート


 MDの企業情報

symbol MD
会社名 Mednax Inc. (MEDNAX INC)
分野(sector)   
産業(industry)   
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 メッドナックス(MEDNAX Inc.)は新生児、麻酔、母体胎児、遠隔診断、小児心臓病学及びその他の小児科専門分野の介護を含む医療業務を提供する。  メドナックスは米国の医療関連会社。新生児、母体・胎児、小児、そして麻酔ケア専門の医師サ―ビスを提供。米国内とプエリトルコで、新生児集中治療室内の早産児や合併症などの新生児の臨床ケアのほか、母体・胎児ケア、複雑妊娠や産科ホスピタリストサ―ビス、麻酔ケアサ―ビスなどを行う。本社はフロリダ州。  Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telehealth programs to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional entities, Mednax provides services through a network of more than 2,300 physicians in 39 states and Puerto Rico.
本社所在地 1301 Concord Terrace Sunrise FL 33323 USA
代表者氏名 Cesar L. Alvarez
代表者役職名 Independent Chairman of the Board
電話番号 +1 954-384-0175
設立年月日 1979年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 11875人
url www.mednax.com
nasdaq_url
adr_tso
EBITDA (百万ドル) 557.12900
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 2477.02700
売上高 (百万ドル) 3647.12300
企業価値(EV) (百万ドル) 4392.89200
当期純利益 (百万ドル) 268.62900
決算概要 BRIEF: For the fiscal year ended 31 December 2018 MEDNAX Inc revenues increased 5% to $3.65B. Net income before extraordinary items increased 7% to $268.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Equity in earnings of unconsolidated aff increase from $952K to $6.8M (income) Investment and other income increase of 25% to $4.9M (income).

 MDのテクニカル分析


 MDのニュース

   Pediatrix Medical Group 2022 Third Quarter Conference Call/Webcast Scheduled for Thursday, November 3, 2022  2022/10/21 10:45:00 Kwhen Finance
   Pediatrix: 5 Graphs Suggest A Buy (NYSE:MD)  2022/09/29 16:52:39 Seeking Alpha
From the deeper analysis of the numbers, I believe Pediatrix has the economic pillars to re-rate to the upside. Click here to see why MD stock is a buy at the current levels.
   SMART Mechanical Department Reaches Tentative Agreement With the NCCC  2022/09/11 15:00:00 Kwhen Finance
   7 Cheap Stocks That Could Increase 10X by 2027  2022/08/31 18:23:05 InvestorPlace
As I was preparing to write about cheap stocks to buy that could increase by ten times over the next few years, I wondered what measuring stick I should use to appropriately identify names that were down but definitely not out. I looked online for a few ideas. For example, NerdWallet recently defined cheap stocks as S&P 500 companies whose share price traded between $5 and $20, but had risen so far this year. InvestorPlace contributor Brian Paradza focused on the PEG ratio — defined as the price–earnings ratio divided by firms’ earnings per share growth — to find some stocks to buy and hold for the long haul. Lastly, Barron’s used the enterprise value-sales ratio to find cheap tech stocks . The publication noted that the ratio factors in cash and debt, instead of just market capitalization, making it a more compelling metric than price-sales. So, based very loosely on these three metrics, I’m going to select seven stocks from the S&P 1500 from seven different sectors. I believe that all of these names have a shot at appreciating ten times by 2027.
   Mednax''s Return on Invested Capital Overview  2022/08/12 14:02:50 Benzinga
According to Benzinga Pro, during Q2, Mednax (NYSE: MD ) earned $27.14 million, a 228.05% increase from the preceding quarter. Mednax also posted a total of $486.03 million in sales, a 0.79% increase since Q1. In Q1, Mednax brought in $482.23 million in sales but lost $21.19 million in earnings. Why Is ROIC Significant? Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company''s ROIC. A higher ROIC is generally representative of successful … Full story available on Benzinga.com
   Middle East Missile Defense Markets Report 2022: Strategic Partnering to Transform Indigenous Defense Capabilities and Drive Growth Strategies  2022/08/02 15:45:00 Kwhen Finance
   Pediatrix Stock: Seeking 46% Return Objective As Speculative Buy (NYSE:MD)  2022/07/14 04:06:53 Seeking Alpha
Pediatrix has idiosyncratic risk drivers that have yet to be priced in at the market level, by estimate. MD''s price action points to a reversal from recent lows.
   Mednax – Consensus Indicates Potential -1.5% Downside  2022/06/29 10:57:27 DirectorsTalk
Mednax found using ticker (MD) have now 10 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 30 and 14 calculating the mean target price we have 21. With the stocks previous close at 21.32 this now indicates there is a potential downside of -1.5%. The day 50 moving average is 19.84 and the 200 day MA is 24.3. The market cap for the company is $1,861m. You can visit the company''s website by visiting: https://www.mednax.com [stock_market_widget type="chart" template="basic" color="green" assets="MD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $1,833m based on the market concensus. MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
   Mednax to rename as Pediatrix Medical Group  2022/06/21 11:23:14 Seeking Alpha
Mednax (MD) said it will change its corporate name to Pediatrix Medical Group Inc., effective after the close of the market on July 1.The company added that its common stock will…
   Mednax – Consensus Indicates Potential 5.5% Upside  2022/06/09 11:43:57 DirectorsTalk
Mednax with ticker code (MD) now have 10 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The target price ranges between 30 and 14 calculating the mean target price we have 21.5. With the stocks previous close at 20.38 this now indicates there is a potential upside of 5.5%. The day 50 moving average is 20.77 and the 200 day moving average is 25.1. The company has a market capitalisation of $1,744m. Company Website: https://www.mednax.com [stock_market_widget type="chart" template="basic" color="green" assets="MD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $1,840m based on the market concensus. MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
   Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference  2022/02/23 12:00:00 Business Wire
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference
   MEDNAX, Inc. (MD) CEO Mark Ordan on Q4 2021 Results - Earnings Call Transcript  2022/02/17 18:06:07 Seeking Alpha
   Mednax Q4 Earnings Beat Estimates, Sees FY22 EBITDA Of At Least $270M  2022/02/17 13:21:52 Benzinga
Mednax Inc (NYSE: MD ) reports Q4 adjusted EPS of $0.52 , more than double from $0.25 a year ago and beating the consensus of $0.44. Q4 revenues reached $498.5 million, compared to $416.6 million for the prior-year period and beating the consensus of $483.83 million. Mednax''s overall same-unit revenue increased by 17.6%, modestly complemented by net acquisition activity. Same-unit revenue from net reimbursement-related … Full story available on Benzinga.com
   MEDNAX, INC. – 10-K – MANAGEMENTapos;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  2022/02/17 12:09:36 InsuranceNewsNet
Mednax is a leading provider of physician services including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. Our national network is comprised of affiliated physicians who provide clinical care in 38 states and Puerto Rico. At December 31, 2021, our national network comprised over 2,400 affiliated physicians,… The post MEDNAX, INC. – 10-K – MANAGEMENT''S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS appeared first on InsuranceNewsNet .
   Mednax to Present at SVB Leerink 11th Annual Global Healthcare Conference  2022/02/17 11:45:00 Kwhen Finance

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 MEDNAX INC MD )

 twitter  (公式ツイッターやCEOツイッターなど)